Literature DB >> 4522247

Immunity to influenza in ferrets. VII. Effect of previous infection with heterotypic and heterologous influenza viruses on the response of ferrets to inactivated influenza virus vaccines.

C McLaren, C W Potter.   

Abstract

Normal ferrets did not produce serum antibody following immunization with 200 i.u. of inactivated A/Hong Kong/68 influenza virus vaccine and were found to be susceptible to subsequent challenge infection with A/Hong Kong/68 virus. High titres of virus were recovered from nasal washings collected 3 days after infection, serum antibody was produced, increased nasal protein was detected and HI antibody was detected in nasal washings. Ferrets infected with influenza virus A/PR/8/34 7 weeks before immunization with inactivated A/HK/68 virus did, however, produce serum HI antibody to A/HK/68 virus. This antibody conferred partial immunity to challenge infection with A/HK/68 virus, as shown by decreased titres of virus in nasal washings and reduced levels of nasal protein. Previous infection of ferrets with influenza virus B/Ann Arbor/66 did not result in the production of serum antibody to A/HK/68 virus following immunization with A/HK/68 vaccine and the animals were completely susceptible to subsequent challenge infection with A/HK/68 virus. Differences in the amount of nasal protein and nasal antibody produced after A/HK/68 infection were also found in ferrets previously infected with either A/PR/8/34 or B/AA/66 virus, compared with normal ferrets.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4522247      PMCID: PMC2130253          DOI: 10.1017/s0022172400023251

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  13 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Enhanced response to influenza A vaccines in hamsters primed by prior heterotype influenza infection.

Authors:  R Jennings; C W Potter
Journal:  Arch Gesamte Virusforsch       Date:  1973

3.  Immunity to influenza in ferrets. IV. Antibody in nasal secretions.

Authors:  S L Shore; C W Potter; C McLaren
Journal:  J Infect Dis       Date:  1972-10       Impact factor: 5.226

4.  Immunity to influenza in ferrets. I. Response to live and killed virus.

Authors:  C W Potter; J S Oxford; S L Shore; C McLaren; C Stuart-Harris
Journal:  Br J Exp Pathol       Date:  1972-04

5.  Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine.

Authors:  E D Kilbourne; J L Schulman; G C Schild; G Schloer; J Swanson; D Bucher
Journal:  J Infect Dis       Date:  1971-11       Impact factor: 5.226

6.  Pathogenesis of influenza in ferrets. I. Tissue and blood manifestations of disease.

Authors:  R F Haff; P W Schriver; C G Engle; R C Stewart
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

7.  Original antigenic sin in ferrets: the response to sequential infections with influenza viruses.

Authors:  R G Webster
Journal:  J Immunol       Date:  1966-08       Impact factor: 5.422

8.  Immunity to influenza in ferrets. V. Immunization with inactivated virus in adjuvant 65.

Authors:  C W Potter; C McLaren; S L Shore
Journal:  J Hyg (Lond)       Date:  1973-03

9.  Immunity to influenza in ferrets. 8. Serological response of ferrets to influenza virus vaccines after infection with heterotypic strains of influenza.

Authors:  C McLaren; C W Potter
Journal:  Med Microbiol Immunol       Date:  1973-09-26       Impact factor: 3.402

10.  Disquisitions of Original Antigenic Sin. I. Evidence in man.

Authors:  R G Webster
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

View more
  15 in total

1.  Monoclonal antibodies detect M-protein epitopes on the surface of influenza virions.

Authors:  L Joassin; C Vincenzotto; J M Cloes; M Bouchet; M Reginster
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Immunity to influenza in ferrets. 13. Protection against influenza infection by serum antibody to homologous haemagglutinin or neuraminidase antigens.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

3.  Immunity to influenza in ferrets. X. Intranasal immunization of ferrets with inactivated influenza A virus vaccines.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

4.  Immunity to influenza in ferrets. XII. Immunization of ferrets with TNBP-split influenza virus vaccine.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  Arch Gesamte Virusforsch       Date:  1974

5.  Immunity to influenza in ferrets. XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  J Hyg (Lond)       Date:  1974-12

6.  Matrix protein from influenza A virus and its role in cross-protection in mice.

Authors:  R G Webster; V S Hinshaw
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

7.  Immunoglobulin M and G antibody response to type- and subtype-specific antigens after primary and secondary exposures of mice to influenza A viruses.

Authors:  N J Gonchoroff; A P Kendal; D J Phillips; C B Reimer
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

8.  Influenza virus infection of the guinea pig: immune response and resistance.

Authors:  J P Phair; C A Kauffman; R Jennings; C W Potter
Journal:  Med Microbiol Immunol       Date:  1979-01-24       Impact factor: 3.402

9.  Immunity to influenza in ferrets. XIV: Comparative immunity following infection or immunization with live or inactivated vaccine.

Authors:  R J Fenton; A Clark; C W Potter
Journal:  Br J Exp Pathol       Date:  1981-06

10.  Outcome of influenza infection: effect of site of initial infection and heterotypic immunity.

Authors:  R A Yetter; S Lehrer; R Ramphal; P A Small
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.